AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,655 | +58.0% | 1,725,089 | -2.5% | 0.01% | +57.1% |
| Q2 2023 | $1,680 | -5.0% | 1,770,147 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $1,768 | +69.0% | 1,770,147 | +20.4% | 0.01% | +60.0% |
| Q4 2022 | $1,046 | -99.9% | 1,469,892 | +24.4% | 0.01% | +25.0% |
| Q3 2022 | $758,000 | -26.6% | 1,181,757 | +5.2% | 0.00% | -20.0% |
| Q2 2022 | $1,033,000 | -14.2% | 1,123,564 | +23.0% | 0.01% | 0.0% |
| Q1 2022 | $1,204,000 | -10.3% | 913,457 | +161.8% | 0.01% | 0.0% |
| Q4 2021 | $1,343,000 | +445.9% | 348,953 | +686.9% | 0.01% | +400.0% |
| Q3 2021 | $246,000 | – | 44,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |